Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 147

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 147
---
 aggregated with all other
Common Shares then beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act
and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor and its affiliates (on an aggregated
basis) of more than 4.99% of the outstanding voting power or number of Common Shares (the “Beneficial Ownership Limitation”).
Upon the written request of the Investor, the Company shall promptly (but not later than the next business day on which the Transfer Agent
is open for business) confirm orally or in writing to the Investor the number of Common Shares then outstanding. The Investor and the
Company shall each cooperate in good faith in the determinations required under this Section 3.4 and the application of this Section 3.4.
The Investor’s written certification to the Company of the applicability of the Beneficial Ownership Limitation, and the resulting
effect thereof hereunder at any time, shall be conclusive with respect to the applicability thereof and such result absent manifest error.

<div align='center'>5</div>

Section 3.5. Upfront Commitment Fee. In consideration for the Investor’s execution and delivery of this Agreement, the Company shall pay the
Upfront Commitment Fee to the Investor in the form of a pre-funded warrant to purchase Common Stock, in the form of hereto,
simultaneous with the Closing.

<div align='center'>ARTICLE IV

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR</div>

The Investor hereby makes
the following representations, warranties and covenants to the Company:

Section 4.1. Organization and Standing of the Investor. The Investor is a limited liability company duly formed, validly existing and in good standing under
the laws of the Principality of Liechtenstein.

Section 4.2. Authorization and Power. The Investor has the requisite corporate power and authority to enter into and perform its obligations under this Agreement
and to purchase or acquire the Shares in accordance with the terms hereof. The execution, delivery and performance by the Investor of
this Agreement and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary
action, and no further consent or authorization of the Investor or its sole member is required. Each of this Agreement has been duly executed
and delivered by the Investor and constitutes a valid and binding obligation of the Investor enforceable against it